Adverse Effect Clinical Trial
— CHX+ADSOfficial title:
Efficacy of an Anti-Discoloration System (ADS) to Reduce Dental Staining in a 0.12% Chlorhexidine-based Mouthwash
Verified date | March 2016 |
Source | University of Milan |
Contact | n/a |
Is FDA regulated | No |
Health authority | Italy: Ethics Committee |
Study type | Interventional |
Dental staining is the most common local side effect of chlorhexidine (CHX) mouthwashes.
A prospective, cross-over, randomized clinical trial will be carried out in triple blind to
compare the effect on dental staining of two 0.12% CHX mouthwashes: with or without ADS.
Twenty-two healthy subjects will be enrolled. Briefly, the study includes two sequential
stages: in the first phase, we record the "immediate" objective and subjective evaluation of
dental discoloration by spectroscopic and questionnaire-based analyses, at baselines and
after each 21 days long-cycle of mouthwash. A wash-out period between the cycles of 21 days
is performed.
In the second phase, a long-term (after 6 months) subjective evaluation of dental
discoloration was obtained by means of clinical photograph visual analysis and new
questionnaires.
Status | Completed |
Enrollment | 22 |
Est. completion date | July 2012 |
Est. primary completion date | February 2012 |
Accepts healthy volunteers | Accepts Healthy Volunteers |
Gender | Both |
Age group | 18 Years to 40 Years |
Eligibility |
Inclusion Criteria: - a subject had to be free from oral mucosa conditions affecting its integrity and to avoid drug or mouthwash intake during the study and in the previous month (eligibility criteria). Exclusion Criteria: - specific allergy to mouthrinses, presence of periodontitis, and frequent use of CHX-based oral hygiene products. |
Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Crossover Assignment, Masking: Double Blind (Subject, Caregiver, Investigator, Outcomes Assessor)
Country | Name | City | State |
---|---|---|---|
Italy | University of Milan | Milano |
Lead Sponsor | Collaborator |
---|---|
University of Milan |
Italy,
Bernardi F, Pincelli MR, Carloni S, Gatto MR, Montebugnoli L. Chlorhexidine with an Anti Discoloration System. A comparative study. Int J Dent Hyg. 2004 Aug;2(3):122-6. — View Citation
Cortellini P, Labriola A, Zambelli R, Prato GP, Nieri M, Tonetti MS. Chlorhexidine with an anti discoloration system after periodontal flap surgery: a cross-over, randomized, triple-blind clinical trial. J Clin Periodontol. 2008 Jul;35(7):614-20. doi: 10.1111/j.1600-051X.2008.01238.x. Epub 2008 Apr 16. — View Citation
Li W, Wang RE, Finger M, Lang NP. Evaluation of the antigingivitis effect of a chlorhexidine mouthwash with or without an antidiscoloration system compared to placebo during experimental gingivitis. J Investig Clin Dent. 2014 Feb;5(1):15-22. doi: 10.1111/jicd.12050. Epub 2013 Jun 14. — View Citation
Solís C, Santos A, Nart J, Violant D. 0.2% chlorhexidine mouthwash with an antidiscoloration system versus 0.2% chlorhexidine mouthwash: a prospective clinical comparative study. J Periodontol. 2011 Jan;82(1):80-5. doi: 10.1902/jop.2010.100289. Epub 2010 Jul 27. — View Citation
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Dental Staining - spectroscopic evaluation | dental color before and after the two treatments | 21 days | No |
Secondary | Dental Staining - visual evaluation | dental color before and after the two treatments | 21 days | No |
Secondary | Dental Staining - visual evaluation on images | dental color before and after the two treatments | 21 days of treatments, re-analysis of images after 6 months from the end of the trial | No |
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT05035888 -
Prophylactic Norepinephrine and Phenylephrine Boluses for Postspinal Anesthesia Hypotension
|
N/A | |
Completed |
NCT04028791 -
Sickle Cell Trait and Exercise, Effect of Hot Environment
|
N/A | |
Completed |
NCT04556357 -
Norepinephrine Prophylaxis for Postspinal Anesthesia Hypotension in Parturients With Preeclampsia
|
N/A | |
Completed |
NCT04118322 -
The Effect of Peppermint Oil on Nausea, Vomiting and Retching in Cancer Patients Undergoing Chemotherapy
|
N/A | |
Recruiting |
NCT03456544 -
Vancomycin-Associated Acute Kidney Injury: A Cross-Sectional Study From a Multi- Center in China
|
||
Completed |
NCT03723109 -
Airway Management During TCI vs RSI Anesthesia Induction
|
||
Completed |
NCT03316417 -
Study of Adverse Renal Effects of Immune Checkpoints Inhibitors
|
||
Completed |
NCT05712018 -
Comparison of Different HES Coload Volumes on the 90% ED of Norepinephrine
|
N/A | |
Not yet recruiting |
NCT04576663 -
Phenylephrine Prophylaxis for Postspinal Anesthesia Hypotension in Parturients With Preeclampsia
|
N/A | |
Completed |
NCT03006042 -
Pharmacokinetics of BPV Following Bilateral US-guided TAP Block for C-section
|
N/A | |
Completed |
NCT03011775 -
Effect of Pioglitazone on Insulin Resistance, Atherosclerosis Progression and Clinical Course of Coronary Heart Disease
|
Phase 4 | |
Completed |
NCT04556370 -
Norepinephrine Prophylaxis for Postspinal Anesthesia Hypotension in Parturients With Preeclampsia.
|
N/A | |
Completed |
NCT03706755 -
Comparison of Two Doses of Norepinephrine in Preventing Hypotension After Spinal Anesthesia
|
Phase 4 | |
Completed |
NCT02768168 -
The Effects of Dezocine Pretreatment on Dexamethasone Induced Perineal Irritation
|
N/A | |
Completed |
NCT02854787 -
Intravenous Bolus of Phenylephrine vs. Norepinephrine in Preventing Hypotension After Spinal Anesthesia
|
Phase 4 | |
Completed |
NCT04272567 -
Norepinephrine Prophylaxis for Postspinal Anesthesia Hypotension
|
N/A | |
Recruiting |
NCT05310331 -
Donafenib for Recurrent Cervical Cancer
|
Phase 2 | |
Completed |
NCT05690334 -
Different Crystalloid Coload Volumes on the 90% ED of Norepinephrine
|
N/A | |
Not yet recruiting |
NCT06467045 -
Frequency of Adverse Events in Pediatric Patients Receiving Sedation for Magnetic Resonance Imaging
|
||
Completed |
NCT05475873 -
Ondansetron for Postspinal Anesthesia Hypotension
|
N/A |